115 related articles for article (PubMed ID: 4024566)
1. [Importance of the cyclophosphane administration regimen for its immunomodulating and antitumor effect in experimental chemotherapy].
Kovbasiuk SA
Vopr Onkol; 1985; 31(7):91-7. PubMed ID: 4024566
[TBL] [Abstract][Full Text] [Related]
2. [Effect of cyclophosphane on the suppressor activity of spleen cells in mice with transplantable tumors].
Kovbasiuk SA; Iudin VM; Kushko LIa; Semenova-Kobzar' RA
Eksp Onkol; 1985; 7(5):60-3. PubMed ID: 2933244
[TBL] [Abstract][Full Text] [Related]
3. [Immunomodulating effect of cyclophosphamide in experimental chemotherapy of transplanted tumors].
Kovbasiuk SA; Iudin VM; Kravchenko SP
Eksp Onkol; 1985; 7(2):67-70. PubMed ID: 3874055
[TBL] [Abstract][Full Text] [Related]
4. [Immunomodulating effect of cyclophosphane under different modes of administration to mice].
Kovbasiuk SA; Iudin VM; Kravchenko SP
Tsitologiia; 1985 Mar; 27(3):316-21. PubMed ID: 2581345
[TBL] [Abstract][Full Text] [Related]
5. Effects of Corynebacterium granulosum on weight and histology of lymphoid organs, response to mitogens, skin allografts, and a syngeneic fibrosarcoma in mice.
Milas L; Basic I; Kogelnik HD; Withers HR
Cancer Res; 1975 Sep; 35(9):2365-74. PubMed ID: 807323
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver.
Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H
Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826
[TBL] [Abstract][Full Text] [Related]
7. [Method of assessing the functional activity of tumor-associated suppressor cells].
Iudin VM; Semenova-Kobzar' RA; Kushko LIa
Eksp Onkol; 1984; 6(6):37-41. PubMed ID: 6241144
[TBL] [Abstract][Full Text] [Related]
8. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
9. [Effect of the rhythm of cyclophosphamide administration on its antitumor action and on the immune response of mice with methylcholanthrene-induced sarcoma].
Gordienko SP; Bergol'ts VM; Botsmanov KV
Biull Eksp Biol Med; 1974 Jul; 78(7):87-90. PubMed ID: 4451721
[No Abstract] [Full Text] [Related]
10. Immune response of mice to sarcoma I allograft studied by adoptive transfers of spleen, thymus, and lymph node cells to secondary recipients.
Vidrnová M; Nouza K; Panajotovová V
Neoplasma; 1985; 32(4):451-61. PubMed ID: 4047256
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the effectiveness of regional interleukin-2 dependent adoptive immunocytotherapy of mice with transplanted rhabdomyosarcoma].
Semenova-Kobzar' RA; Iudin VM; Kushko LIa; Iakhimovich LV; Berezhnaia NM
Eksp Onkol; 1990; 12(3):50-2. PubMed ID: 2344825
[TBL] [Abstract][Full Text] [Related]
12. The effects of cyclophosphamide and irradiation singly and in combination upon SaI growth in A/J mice.
Anderson RE; Williams WL; Tokuda S
Am J Pathol; 1987 May; 127(2):373-9. PubMed ID: 3555105
[TBL] [Abstract][Full Text] [Related]
13. Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer.
Masuda E; Maeda H
Cancer Res; 1996 Apr; 56(8):1868-73. PubMed ID: 8620506
[TBL] [Abstract][Full Text] [Related]
14. The activity of regional nodes in the evolution of immune responses to allogeneic and isogeneic tumors.
Barna B; Deodhar SD
Cancer Res; 1975 Apr; 35(4):920-6. PubMed ID: 1116149
[TBL] [Abstract][Full Text] [Related]
15. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan.
Mizushima Y; Sendo F; Miyake T; Kobayashi H
J Natl Cancer Inst; 1981 Apr; 66(4):659-65. PubMed ID: 6939913
[TBL] [Abstract][Full Text] [Related]
17. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
Basombrío MA; Prehn RT
Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
[No Abstract] [Full Text] [Related]
18. [Action of cyclophosphane and degranol on the T- and B-lymphocyte populations in the lymph nodes when administered endolymphatically].
Davydov VF; Kuzin VB
Farmakol Toksikol; 1986; 49(2):31-5. PubMed ID: 3486778
[TBL] [Abstract][Full Text] [Related]
19. Effect of fractional cyclophosphamide dosage on sheep red blood cell-delayed-type hypersensitivity response in mice.
Rondinone SN; Giovanniello OA; Barrios HA; Nota NR
J Immunol; 1983 Apr; 130(4):1600-3. PubMed ID: 6220061
[TBL] [Abstract][Full Text] [Related]
20. [Effect high-altitude conditions on the antitumor activity of cyclophosphane and its action on lymphoid tissue cells].
Kulish OP
Eksp Onkol; 1985; 7(3):60-3. PubMed ID: 3160572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
